Pharmafile Logo
Pharmafocus logo
Advanced Search

ergomed

Showing 6 posts of 6 posts found.

eusa

EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients

April 2, 2020
Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab

EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …

News
shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020
Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …

News
stephen_stamp

Former Ergomed CEO appointed as Midatech’s Chief Financial Officer

September 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ergomed, midatech

Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect. He will be …

Appointment
stephen_stamp

Ergomed announces board changes

January 19, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …

Appointment
anderw_mackie_picture

Ergomed strengthens management team and board

July 15, 2015
Research and Development, Sales and Marketing Andrew Mackie, ergomed

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …

Appointment
peter_george_ceo_clinigen_group

Clinigen chief executive joins Ergomed board

May 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, ergomed, george

UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

  George has over 20 …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026